Unveiling functional heterogeneity in pasteurized Akkermansia muciniphila identifies AKK2645 as a superior postbiotic

Yaqiong Li1, Wenfang Song2, Xiaoli Liu2

  • 1Hunan Province Directly Affiliated TCM Hospital, Zhuzhou, China.

Frontiers in Nutrition
|August 21, 2026
PubMed

Insights

Akkermansia muciniphila strain AKK2645 effectively treats metabolic syndrome by improving gut health, reducing inflammation, and restoring metabolic balance. This precision postbiotic offers a promising new therapeutic avenue for this widespread condition.

Area of Science:

  • Microbiology
  • Immunology
  • Metabolic Research

Background:

  • Metabolic syndrome (MetS) is a growing global health concern requiring novel microbiome-based treatments.
  • Significant heterogeneity exists among Akkermansia muciniphila strains regarding their therapeutic potential.

Purpose of the Study:

  • To systematically evaluate 42 pasteurized Akkermansia muciniphila strains for their efficacy in alleviating MetS.
  • To identify and characterize the most effective strain for MetS intervention.

Main Methods:

  • Systematic functional screening of 42 Akkermansia muciniphila strains using cell and mouse models.
  • Evaluation of strain AKK2645's efficacy in diet-induced obesity, glucose homeostasis, and hepatic steatosis models.
  • Analysis of host immunity modulation, gut microbiota composition, and GLP-1 signaling.

Main Results:

  • Strain Akkermansia muciniphila YGMCC2645 (AKK2645) demonstrated superior efficacy in attenuating obesity, improving glucose control, and reducing fatty liver.
  • AKK2645 modulated host immunity by decreasing pro-inflammatory cytokines and increasing anti-inflammatory markers.
  • AKK2645 favorably altered gut microbiota composition and activated intestinal GLP-1 signaling.

Conclusions:

  • Strain-specific functional differences are crucial for postbiotic efficacy in treating MetS.
  • Akkermansia muciniphila strain AKK2645 is identified as a potent, precision postbiotic for metabolic syndrome intervention.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...